Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Japan's Takeda Reportedly Offering $12B For Europe's Nycomed

May 12 2011

• By The Pink Sheet Daily

Related Content

Takeda Unveils R&D, Commercial Realignments To Try For Post-Patent Gains

May 11 2011

Specialty Pharma In Europe: Is Long-Term Independence Still An Option?

Apr 01 2011

Nycomed Prepares To Launch First Nonprescription PPI With EU-Wide Approval

May 18 2009

Nycomed CEO Hakan Bjorklund On Emerging Markets As Core Focus For Growth: An Interview With PharmAsia News

Oct 06 2010

Russia Pledges $3.9 Billion For Local Pharma Growth, As Big Pharma Scrambles To Set Up Shop

Dec 22 2010

Takeda’s Millennium Buy Brings In Potential Cancer Blockbuster Velcade

Apr 14 2008

Additional Topics

Japan Asia Pacific Europe BioPharmaceutical

More from Japan

More from Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window